AMENDED AND RESTATED COLLABORATION AGREEMENTCollaboration Agreement • August 9th, 2019 • Tg Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 9th, 2019 Company Industry JurisdictionTHIS AMENDED AND RESTATED COLLABORATION AGREEMENT (the “Agreement”) is dated as of June 19, 2019 by and between Checkpoint Therapeutics, Inc., a Delaware corporation organized having its place of business at 2 Gansevoort Street, New York, NY 10014 (“CTI”), and TG Therapeutics, Inc. located at 2 Gansevoort Street, New York, NY 10014 (“TGTX”). CTI, on the one hand, and TGTX, on the other hand, shall each be referred to herein as a “Party” or, collectively, as the “Parties.”
Amended and Restated Collaboration AGREEMENTCollaboration Agreement • August 8th, 2019 • Checkpoint Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 8th, 2019 Company Industry JurisdictionTHIS AMENDED AND RESTATED COLLABORATION AGREEMENT (the “Agreement”) is dated as of June 19, 2019 by and between Checkpoint Therapeutics, Inc., a Delaware corporation organized having its place of business at 2 Gansevoort Street, New York, NY 10014 (“CTI”), and TG Therapeutics, Inc. located at 2 Gansevoort Street, New York, NY 10014 (“TGTX”). CTI, on the one hand, and TGTX, on the other hand, shall each be referred to herein as a “Party” or, collectively, as the “Parties.”
Collaboration AGREEMENTCollaboration Agreement • July 11th, 2016 • Checkpoint Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 11th, 2016 Company Industry JurisdictionTHIS COLLABORATION AGREEMENT (the “Agreement”) is dated as of March 3, 2015 (the “Effective Date”) by and between Checkpoint Therapeutics, Inc., a Delaware corporation organized having its place of business at 3 Columbus Circle, New York, NY 10019 (“CTI”), and TG Therapeutics, Inc. located at 3 Columbus Circle, New York, NY 10019 (“TGTX”). CTI, on the one hand, and TGTX, on the other hand, shall each be referred to herein as a “Party” or, collectively, as the “Parties.”
Collaboration AGREEMENTCollaboration Agreement • March 24th, 2016 • Checkpoint Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 24th, 2016 Company Industry JurisdictionTHIS COLLABORATION AGREEMENT (the “Agreement”) is dated as of March 3, 2015 (the “Effective Date”) by and between Checkpoint Therapeutics, Inc., a Delaware corporation organized having its place of business at 3 Columbus Circle, New York, NY 10019 (“CTI”), and TG Therapeutics, Inc. located at 3 Columbus Circle, New York, NY 10019 (“TGTX”). CTI, on the one hand, and TGTX, on the other hand, shall each be referred to herein as a “Party” or, collectively, as the “Parties.”
Collaboration AGREEMENTCollaboration Agreement • May 11th, 2015 • Tg Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 11th, 2015 Company Industry JurisdictionTHIS COLLABORATION AGREEMENT (the “Agreement”) is dated as of March 3, 2015 (the “Effective Date”) by and between Checkpoint Therapeutics, Inc., a Delaware corporation organized having its place of business at 3 Columbus Circle, New York, NY 10019 (“CTI”), and TG Therapeutics, Inc. located at 3 Columbus Circle, New York, NY 10019 (“TGTX”). CTI, on the one hand, and TGTX, on the other hand, shall each be referred to herein as a “Party” or, collectively, as the “Parties.”